URGN
UroGen Pharma Ltd
41.40$
-3.2%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.54 | -0.36 | -0.95 | -0.64 | -0.64 | -0.29 | -0.89 | -0.83 | -0.88 | -0.78 | -0.90 | -0.66 | -3.15 | |
| 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.05 | |
| 0.07 | 0.07 | 0.08 | 0.10 | 0.08 | 0.07 | 0.06 | 0.06 | 0.06 | 0.06 | 0.09 | 0.11 | 0.32 | |
| -0.03 | 0.18 | -0.12 | 0.07 | -0.21 | 0.33 | -0.05 | 0.11 | -0.28 | -0.37 | -0.60 | -0.49 | -1.72 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.01 | -0.31 | 0.40 | 0.33 | -2.48 | 1.29 | -0.55 | 0.60 | 0.65 | 0.56 | -0.41 | 0.03 | 0.80 | |
| – | – | – | – | – | 0.00 | 0.00 | 0.00 | 0.00 | -0.04 | 1.30 | -0.01 | 1.25 | |
| 3.59 | 0.00 | 1.64 | 2.72 | 0.92 | 0.00 | 0.00 | 0.01 | 0.17 | 0.64 | 1.30 | 0.01 | 2.09 | |
| 3.07 | -0.67 | 1.09 | 2.40 | -2.20 | 1.00 | -1.43 | -0.23 | -0.05 | 0.42 | -0.02 | -0.61 | -0.27 | |
| -0.54 | -0.36 | -0.95 | -0.65 | -0.64 | -0.29 | -0.89 | -0.84 | -0.88 | -0.78 | -0.90 | -0.66 | -3.16 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.